Ga-68-DOTATOC PET/CT Reveals Meningeal Metastasized Uveal Melanoma
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Gallium-68 DOTATOC PET/CT imaging successfully identified melanoma recurrence in a patient initially suspected of having a meningioma. This nuclear imaging technique is a valuable tool for staging uveal melanoma, particularly for cranial lesions.
Area Of Science
- Nuclear Medicine
- Oncology
- Ophthalmology
Background
- Cerebral MRI revealed new findings, prompting investigation for potential meningioma.
- A history of treated uveal melanoma raised suspicion for recurrence.
Purpose Of The Study
- To evaluate the utility of Ga-68-DOTATOC PET/CT in diagnosing suspected meningioma versus melanoma recurrence.
- To assess the effectiveness of Ga-68-DOTATOC PET/CT for staging uveal melanoma.
Main Methods
- Positron emission tomography/computed tomography (PET/CT) using Gallium-68 DOTATOC (68Ga-DOTATOC).
- Correlation with prior medical history and histopathological examination.
Main Results
- PET/CT demonstrated significant uptake in the right eye and multiple intra- and extracranial lesions.
- Histology confirmed metastatic melanoma, indicating recurrence.
- Findings were consistent with advanced metastatic disease, not meningioma.
Conclusions
- Ga-68-DOTATOC PET/CT is a useful tool for diagnosing suspected meningioma when melanoma recurrence is a possibility.
- This imaging modality serves as an effective alternative for staging uveal melanoma, especially for cranial metastases.
- 68Ga-DOTATOC PET/CT can detect cranial findings often missed by F-18-FDG-PET/CT.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
